|
|
Expression, Purification and Bioactivity Identification of Recombinant Human Leukemia Inhibitory Factor (hLIF) Fusion Protein |
SUN Jing, WANG Bin, DUAN Zhi-qing, HU Ning-zhu, LI Jian-fang, LI Yan-han, HU Yun-zhang |
Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China |
|
|
Abstract Objective: To express recombinant human Leukemia inhibitory factor (hLIF) fusion protein in prokaryotic cells, purify and identify the bioactivity of expressed product. Methods: The hLIF gene was cloned into vector pThioHisA, and the constructed recombinant plasmid pThioHisA-hLIF was transformed to E.coli BL21(DE3) for expression under induction of IPTG. After the expression product waspurified by affinity chromatography, the fusion protein was tested for its specificity by western blot detection. To assess the bioactivity of the hLIF fusion protein expressed in E.coli, it was tested to maintain the pluripotency of the mouse embryonic stem cells in feeder-independent culture system. Results: Lower the induction temperature and prolong the induction time can increase soluble hLIF fusion protein expression. The recombinant protein reached a purity of more than 95% after purification, and its specificity was successfully proved by western blot detection. In feeder-independent culture system, adding hLIF fusion protein can effectively maintain the mouse embryonic stem cells in an undifferentiated state. Conclusion: The recombinant hLIF fusion protein was highly expressed in E.coli and showed good specificity, which lay the foundation for stem cells research and further research on hLIF biological functions.
|
Received: 15 January 2013
Published: 25 May 2013
|
|
|
|
[1] 葛秀国, 徐小明, 李勇,等.白血病抑制因子与胚胎干细胞. 中国生物工程杂志, 2003, 23(12):22-30. Ge XG, Xu XM, Li Y, et al. Leukemia inhibitory factor and embryonic stem cells. China Biotechnology, 2003, 23(12):22-30. [2] Cartwright P, McLeanC, Sheppard A, et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development, 2005, 132(5): 885-896. [3] Guasch G, Fuchs E. Mice in the world of stem cell biology. Nat Genet, 2005, 37(11):1201–1206. [4] Smith A G, Heath J K, Donaldson D D, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature, 1988,336(6200):688-90. [5] Williams R L, Hilton D J, Pease S, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature, 1988, 336(6200):684-687. [6] Hanna J, Cheng A W, Saha K, et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA, 2010, 107(20):9222–9227. [7] Tomala M, Lavrentieva A, Moretti P, et al. Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner. Protein Expr Purif, 2010, 73(1):51-57. [8] Imsoonthornruksa S, Noisa P, Parnpai R, et al. A simple method for production and purification of soluble and biologically active recombinant human leukemia inhibitory factor (hLIF) fusion protein in Escherichia coli. J Biotechnol, 2011, 151(4):295-302. [9] 韩甫,叶荣,鲍柳君,等.小鼠胚胎干细胞无饲养层培养及其生物学特性. 苏州大学学报(医学版), 2009, 29(2):204-206. Han F,Ye R, Bao L J, et al. Culture of mouse embryonic stem cells and their biological features without feeder layer cells. Suzhou University Journal of Medical Science, 2009, 29(2):204-206. [10] 刘登华,张苏明,闫秋月,等.无饲养层条件原代培养小鼠胚胎干细胞的实验研究. 神经损伤与功能重建, 2011, 6(3):157-160. Liu D H, Zhang S M, Yan Q Y, et al. Culture of mural embryonic stem cells under feeder-free condition. Neural Injury and Functional Reconstruction, 2011, 6(3):157-160. [11] 赵政凯,刘畅,刘福强,等. 饲养层细胞体系及白血病抑制因子对维持小鼠胚胎干细胞未分化状态的作用. 解剖科学进展, 2009, 15(3):283-285,289. Zhao Z K, Liu C, Liu F Q, et al. Effect of feeder layer culture system and leukemia inhibitory factor on keeping mouse embryonic stem cells in undifferentiation. Progress of Anatomical Sciences, 2009, 15(3):283-285,289. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|